期刊文献+

表面增强激光解析/离子化飞行时间质谱技术在神经管缺陷胎儿母亲血清标志物筛查中的应用

Application of surface enhanced laser desorption/ionization time-of-flight mass spectrometry in screening of markers in maternal serum with fetuses of neural tube defects
原文传递
导出
摘要 目的:探讨表面增强激光解析/离子化飞行时间质谱(SELDI—TOF—MS)技术在筛选神经管缺陷胎儿母亲血清蛋白质标志物中的应用。方法:经超声确诊为胎儿神经管缺陷的孕妇17例和正常孕妇14例,神经管缺陷包括脊柱裂7例、无脑儿4例、脑膨出6例。所有孕妇均于清晨空腹取外周静脉血5ml,离心后取血清,然后用CM10芯片按照蛋白质芯片标准操作流程进行检测。采用PBSIIC型蛋白质芯片阅读机读取数据,设定优化相对分子质量范围1000~30000Da。统计分析使用Ciphergen protein chip3.1.1软件。结果:所有神经管畸形胎儿母亲血清标本共检测到55个差异蛋白峰,其中12个与正常组比较存在统计学意义,包括8种蛋白质/多肽高表达,质荷比(m/z)分别为4105、4297、4188、6650、8583、3282、2750、3327;4种蛋白质/多肽低表达,m/z分别为5497,28078,9155,9434。建立决策分类树,得到了带有3个终结点的决策分类树,获得了2个标志性蛋白质,m/z分别为4105、7788。神经管缺陷诊断模型的灵敏度为88.2%,特异度为100%。结论:应用SELDI技术可以筛查出神经管缺陷的特异性蛋白质标志物,是神经管缺陷产前诊断的重要方法之一。 Objective: To explore the application of surface enhanced laser desorption/ionization time -of- flight mass spectrometry (SELDI-TOF- MS) in screening of protein markers in maternal serum with fetuses of neural tube defects. Methods: 17 pregnant women whose fetuses were diagnosed as neural tube defects by ultrasound (7 cases of spina bifida, 4 cases of anencephaly fetus and 6 cases of encephalocele) and 14 normal pregnant women were selected, 5 ml peripheral venous blood of all the pregnant women were obtained early in the morning, then serum was purified from blood by centrifugation, and SELDI - TOF - MS was detected by PBS II C protein chip biosys- tern, the optimal detection range of molecular weight was 1 000 -30 000Da. The data were analysed by Ciphergen protein chip 3.1.1 software. Results: 55 different protein peaks in maternal serum samples were detected, there was significant difference in 12 protein peaks between study group and control group, including 8 kinds of high expression proteins/peptides, their m/z were 4 105, 4 297, 4 188, 6 650, 8 583, 3 282, 2 750 and 3 327, respectively; 4 kinds of low expression proteins/peptides, their m/z were 5 497, 28 078, 9 155 and 9 434, respectively. 3 decision trees with terminal node and 2 protein markers were gained, whose m/z were 4 105 and 7 788, respectively. The specificity and sensitivity of diagnostic model of neural tube defects were 100% and 88. 2%, respectively. Conclusion : SELDI - TOF - MS can screen the specific protein markers of neural tube defects, which is one of the important prenatal diagnostic methods.
出处 《中国妇幼保健》 CAS 北大核心 2010年第5期650-654,共5页 Maternal and Child Health Care of China
基金 国家自然科学基金资助〔30571934〕
关键词 神经管缺陷 表面增强激光解析/离子化飞行时间质谱 产前诊断 蛋白质标志物 Neural tube defects Surface enhanced laser desorption/ionization time -of- flight mass spectrometry Prenatal diagnosis Protein marker
  • 相关文献

参考文献15

  • 1Birnbacher R, Messerschmidt AM, Pollak AP. Diagnosis and prevention of neural tube defect [J]. Curr Opin Urol, 2002, 12 (6) : 461.
  • 2郑明明,胡娅莉.神经管缺陷及其病因学研究[J].国外医学(妇幼保健分册),2003,14(5):282-284. 被引量:12
  • 3Palomaki GE, Williams JR, Haddow JE. Prenatal screening for open neuraltube defects in Maine [J]. N Engl J Med, 1999, 340 (13): 1049.
  • 4Curmingham GC, Tompkinison DG. Cost and effectiveness of the California triple marker prenatal screening program [J]. Genet Med, 1999, 1 (5): 199.
  • 5Cuckle HS. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985 [J]. Prenat Diagn, 1989, 9 (6) : 393.
  • 6Azam AZ, Vial Y, Fawer CL et al. Prenatal diagnosis of congenital cytomegalovirus infection[J]. Obstetrics Gynecology, 2001, 97 (3) :443.
  • 7Wald NJ, Cuckle H, Brock JH et al. Maternal serum -alpha -fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U. K. collaborative study on alpha -fetoprotein in relation to neural- tube defects[J]. Lancet, 1977, 1 (8026): 1323.
  • 8鲍培忠,吴亚农,顾青,柯瑞娥,洪庆,陶春瑾,黄季敏,张晓频.孕妇血清标记物用于严重胎儿缺陷的产前筛选[J].中华妇产科杂志,1997,32(11):649-651. 被引量:42
  • 9Onda T, Tanaka T, Yoshida K et al. Triple marker screening for triso my 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women [J]. J Obstet Gyuaecol Res, 2000, 26 (6): 441.
  • 10Muller F. Prenatal biochemical screening for neural tube defects [J]. Childs Nerv Syst, 2003, 19 (7 -8) : 433.

二级参考文献23

  • 1Joosten P H, Toepoel M, Mariman E C, et al. Promoter haplotype combinations of the platelet-derived growth factor alphareceptor gene predispose to human neural tube defects[J]. Curr Probl Pediatr,2000,30(10) :313 - 332.
  • 2Davidoff M J, Petrini J, Damus K, et al. Neural tube defectspecific infant mortality in the United States[J]. Teratology,2002,66(Suppl 1 ) :S17 - S22.
  • 3Northrup H, Volcik K A. Spina bifida and other neural tube defects[J]. Paediatr Drugs,2000,2(6) :437 - 449.
  • 4Kapur B, Soldin O P, Koren G. Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate[J]. Ther Drug Monit, 2002, 24(5) : 628 - 630.
  • 5Stone D H, McCarron P, Smith G D. Similarities in the epidemiology of neural tube defects and coronary heart disease: is homocysteine the missing link [ J ]. J Epidemiol Community Health. 1999.53(12):789 - 793.
  • 6Bradai R, Siger D, Chakroun R. Folic acid supplementation by 200 microgram per day during the periconceptional period: a necessary public health approach to reducing incidence of spina bifida[J]. Contraceot Fertil Sex. 1999.27(3), 238 - 242.
  • 7Lewis D P, Dyke D C, Stumbo P J. Drug and environmental factors aith adverse pregnancy outcomes[J]. Ann Pharmacother, 1998,32(10) : 1087 - 1095.
  • 8Put N M, Straaten H W, Trijbels F J, et al. Folate, homocysteine and neural tube defects: an overview[J]. Exp Biol Med,2001,226 (4) : 243 - 270.
  • 9Jablonski N G. A possible link between neural tube defects and ultraviolet light exposure[ J ]. Med Hypothese , 1999, 52 (6) : 581 -589.
  • 10Czeizle A E. Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy[J]. Paediatr Drugs, 2000,2 (6) : 437 - 449.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部